Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients

NCT06273800 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT06273800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 14, 2025
Completion date
July 15, 2036
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer